PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China.\', \'University of Chinese Academy of Sciences, Beijing, China.\', \'Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-ScienceChinese Academy of Sciences, Wuhan, Hubei, China.\', \'Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, and Institute of Biology, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China.\', \'Beijing Advanced Innovation Center for Structural Biology, Tsinghua-Peking Joint Center for Life Sciences, School of Life Sciences, Tsinghua University, Beijing, China.\', \'School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.\', \'Dartsbio Pharmaceuticals, Zhongshan, Guangdong, China.\', \'Fudan University, School of Pharmacy, Shanghai, China.\', \'Center for Infectious Disease Research, Westlake Laboratory of Life Sciences and Biomedicine, Key Laboratory of Structural Biology of Zhejiang Province, School of Life Sciences, Westlake University, and Institute of Biology, Westlake Institute for Advanced Study, Hangzhou, Zhejiang, China. zhouqiang@westlake.edu.cn.\', \'Key Laboratory of Special Pathogens and Biosafety, Wuhan Institute of Virology, Center for Biosafety Mega-ScienceChinese Academy of Sciences, Wuhan, Hubei, China. zhangbo@wh.iov.cn.\', \'Drug Discovery Center for Infectious Disease, Nankai University, Tianjin, China. zhangbo@wh.iov.cn.\', \'Biotherapeutics Discovery Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China. wangc@simm.ac.cn.\', \'University of Chinese Academy of Sciences, Beijing, China. wangc@simm.ac.cn.\', \'School of Chinese Materia Medica, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China. wangc@simm.ac.cn.\', \'Dartsbio Pharmaceuticals, Zhongshan, Guangdong, China. wangc@simm.ac.cn.\', \'Fudan University, School of Pharmacy, Shanghai, China. wangc@simm.ac.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41392-021-00740-y
?:doi
?:hasPublicationType
?:journal
  • Signal transduction and targeted therapy
is ?:pmid of
?:pmid
?:pmid
  • 34433803
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • ACE2-targeting monoclonal antibody as potent and broad-spectrum coronavirus blocker.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34433803>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34433803>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all